FDA panel urges Acrotech to speed up study on cancer drugs
(Reuters) - A panel of independent experts to the U.S. health regulator urged Acrotech Biopharma to work with the agency to bring forward the date for...
Stay updated with breaking news from Andy Chen. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
(Reuters) - A panel of independent experts to the U.S. health regulator urged Acrotech Biopharma to work with the agency to bring forward the date for...
Robert Califf’s all-hands email to FDA staff came hours after POLITICO first reported the news of Woodcock’s retirement plans.
'The consensus of the advisory committee is that we have significant concerns about the very prolonged delay and getting these confirmatory studies underway.'
No easy answers for two drugs for rare lymphoma on long cruise with accelerated approval
A panel of independent experts to the U.S. health regulator urged Acrotech Biopharma to work with the agency to bring forward the date for releasing trial data that could confirm benefits of the...